PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me
Loading the index…

Try

GLP-1 TV

How Do Zepbound & Mounjaro Work?

5:16Dec 2023

Today’s cheapest tirzepatide$69/mo at Wellmedr, sale price.Compare all tirzepatide prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.

Our summary

According to the video, Zepbound and Mounjaro are the same once-weekly injection, with the scientific drug name tirzepatide. The presenter says Mounjaro is intended for people with type 2 diabetes, while Zepbound is intended for people without diabetes who struggle to lose weight or live with obesity. She says clinical trial participants lost an average of 20% of their body weight, which she illustrates as about 50 lbs for someone weighing about 250 lbs.

Published by Diabetes Nerd on YouTube

As published by the channel. Not medical advice, and not an endorsement.

What else the video covers

The video explains that the drugs stimulate the GIP and GLP-1 hormones, part of what she calls the incretin effect. She says this system is considered impaired in people with diabetes or weight struggles, and that the drugs help improve it. She distinguishes them from semaglutide drugs, which she says are GLP-1 only and lack the GIP part. Effects she describes include greater insulin sensitivity, less glucose made by the liver, better natural insulin production, feeling full sooner, fewer cravings, and slower digestion that keeps meals from affecting blood sugar as quickly.

On safety, she says side effects are mostly digestive: gas, vomiting, diarrhea, constipation and nausea. She advises raising the dose slowly under a healthcare team's guidance and talking to the team if side effects are severe. She notes the drugs do not cause low blood sugar alone but can when combined with insulin, so insulin doses may need to be lowered. She also mentions a thyroid cancer risk for people with a family history of certain types, and says the medications should be paired with exercise and better food quality.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 0:00 The presenter says Zepbound and Mounjaro are the same drug, tirzepatide, given as a weekly injection, with trial participants losing an average of 20% of body weight.
  2. 0:31 She explains that the drugs stimulate the GIP and GLP-1 hormones, unlike semaglutide drugs, which she says act only on GLP-1.
  3. 1:33 She lists effects including better insulin sensitivity and less glucose made by the liver.
  4. 2:34 She says the drugs make you feel full sooner and slow digestion, which delays the effect of meals on blood sugar.
  5. 3:04 She describes mostly digestive side effects and advises increasing the dose very slowly with a healthcare team.
  6. 4:05 She cautions about low blood sugar when combined with insulin, a thyroid cancer risk with certain family histories, and the need for supportive lifestyle habits.

Key moments

Tap one to play from there.

  1. 0:00 Introduction to medications
  2. 0:36 How the drugs work
  3. 1:15 Benefits and comparisons
  4. 1:52 Mechanisms of action
  5. 3:12 Side effects and dosing
  6. 4:14 Risks and lifestyle

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Zepbound and Mounjaro
Side effects mentioned
vomiting

Questions this video answers

What is the difference between Zepbound and Mounjaro?

According to the video, they are the same drug, tirzepatide. Mounjaro is intended for people with type 2 diabetes, while Zepbound is intended for people without diabetes who struggle to lose weight or live with obesity.

How do Zepbound and Mounjaro work?

The presenter says they stimulate the GIP and GLP-1 hormones. She describes increased insulin sensitivity, reduced glucose output from the liver, feeling full sooner, fewer cravings, and slower digestion.

What are the side effects of Zepbound and Mounjaro?

She says side effects mostly involve the stomach and digestion, including gas, vomiting, diarrhea, constipation and nausea. She advises increasing the dose slowly and talking to a healthcare team if side effects are severe.

How is tirzepatide different from semaglutide?

The presenter says semaglutide drugs such as Ozempic and Wegovy are GLP-1 only and lack the GIP part. She describes the two types as very similar but still different.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • Mounjaro for weight loss, and why Zepbound exists

    Mounjaro is tirzepatide approved for type 2 diabetes. Zepbound is the same molecule from the same maker, approved for weight management, and it goes to the same 15 mg. So unlike Ozempic and Wegovy, there is no dose ceiling pushing you from one to the other: the reason people move is coverage and cash price, not strength. Using Mounjaro for weight is off-label and a prescriber's decision. In the one head-to-head trial, tirzepatide beat semaglutide, 20.2% mean body-weight loss at 72 weeks against 13.7%.

  • Mounjaro side effects: the label's numbers by dose, the low blood sugar risk, and how tirzepatide compares at weight-loss doses

    On Mounjaro's own label, the common side effects are stomach ones and they rise with the dose: nausea in 12, 15 and 18 percent of people at 5, 10 and 15 mg against 4 percent on placebo, diarrhea 12 to 17 against 9, and any gastrointestinal reaction in 37 to 44 percent against 20. Most of it happens while the dose is being raised and fades. Low blood sugar is rare on Mounjaro alone and is mainly a risk when it is added to insulin or a sulfonylurea. Below: the full table, the rare warnings, and why Zepbound's numbers for the same molecule look higher.

  • Zepbound vs Mounjaro: one molecule, two labels, and why the label sets your price

    Zepbound and Mounjaro are both tirzepatide, made by Lilly, injected weekly at the same six doses from 2.5 to 15 mg. Mounjaro is approved for type 2 diabetes and Lilly's own site says it is not a weight-loss drug; Zepbound is the same molecule approved for obesity and sleep apnoea. That label decides everything downstream: insurers cover Mounjaro for diabetes and refuse it for weight, Zepbound is the box a plan can cover for weight, and Zepbound's cash price runs $299 to $699 by dose, while LillyDirect sells Mounjaro from $499 a month at every strength, against a list price of $1,112.16 per fill.

Next steps

Zepbound prices

Insurance

Find more like it

Side effectsDose changeFood noise and cravingsHow it worksThe trialsVomiting

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV